Published by Michele Maatouk on 6th August 2021
(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.
URL: http://www.digitallook.com/dl/news/story/32040080/...